Literature DB >> 5559142

Immunological studies in a patient with ulcerative colitis and sarcoidosis.

D W Watson, H M Friedman, A Quigley.   

Abstract

This report describes a patient with both ulcerative colitis and sarcoidosis. This association is of interest because of the anergy for cellular immunity which was characteristic of the sarcoidosis and the cytotoxic effect of the patient's lymphocytes for allogenic colon epithelial cells which characterized the ulcerative colitis. This concordance of immunological findings suggests that the cytotoxic effect may have a basis other than cellular immunity.

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5559142      PMCID： PMC1411856          DOI： 10.1136/gut.12.7.541

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  9 in total

1.  LYMPHOCYTE INTERACTION: A POTENTIAL HISTOCOMPATIBILITY TEST IN VITRO.

Authors:  F BACH; K HIRSCHHORN
Journal:  Science       Date:  1964-02-21       Impact factor: 47.728

2.  EFFECT OF KVEIM ANTIGEN AND OLD TUBERCULIN ON LYMPHOCYTES IN CULTURE FROM SARCOID PATIENTS.

Authors:  D C COWLING; D QUAGLINO; P K BARRETT
Journal:  Br Med J       Date:  1964-06-06

3.  Carcinoma of the terminal ileum and sarcoidosis in a case of ulcerative colitis.

Authors:  K N Jalan; N MacLean; J M Ross; W Sircus; S T Butterworth
Journal:  Gastroenterology       Date:  1969-03       Impact factor: 22.682

4.  A study of Crohn's syndrome using tissue extracts and the Kveim and Mantoux tests.

Authors:  W J Williams
Journal:  Gut       Date:  1965-10       Impact factor: 23.059

5.  Chronic ulcerative colitis, xanthomatous biliary cirrhosis and sarcoidosis. Report of a case.

Authors:  N P Trujillo; L S Halstead; H E Ticktin
Journal:  Med Ann Dist Columbia       Date:  1967-03

6.  Altered immunologic activity in sarcoidosis.

Authors:  C E Buckley; H Nagaya; H O Sieker
Journal:  Ann Intern Med       Date:  1966-03       Impact factor: 25.391

7.  Effect of lymphocytes from patients with ulcerative colitis on human adult colon epithelial cells.

Authors:  D W Watson; A Quigley; R J Bolt
Journal:  Gastroenterology       Date:  1966-12       Impact factor: 22.682

8.  Inhibition of in vitro cytotoxicity of lymphocytes from patients with ulcerative colitis and granulomatous colitis for allogeneic colonic epithelial cells using horse anti-human thymus serum.

Authors:  R G Shorter; R J Spencer; K A Huizenga; G A Hallenbeck
Journal:  Gastroenterology       Date:  1968-02       Impact factor: 22.682

9.  In vitro studies of ulcerative colitis. II. Cytotoxic action of white blood cells from patients on human fetal colon cells.

Authors:  P PERLMANN; O BROBERGER
Journal:  J Exp Med       Date:  1963-05-01       Impact factor: 14.307
  9 in total
  2 in total

1.  Ulcerative colitis and sarcoidosis.

Authors:  G D Barr; D J Shale; D P Jewell
Journal:  Postgrad Med J       Date:  1986-05       Impact factor: 2.401

2.  Sarcoidosis development during ulcerative colitis remission in a patient with a susceptible human leukocyte antigen serotype.

Authors:  Toshiyuki Sumi; Gen Yamada; Takafumi Yorozuya; Yusuke Tanaka; Yasumasa Tanaka; Yuji Sakuma; Hiroki Takahashi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2021-03-31       Impact factor: 0.670
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.